![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChemCID | |
IUPHAR/BPS | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C13H20Cl2N2 |
Molar mass | 275.22 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
BD-1047 is asigma receptorantagonist, selective for theσ1 subtype. It has effects in animal studies suggestive ofantipsychotic activity and may also be useful in the treatment ofneuropathic pain.[1][2]
More recent studies also suggest a novel role for BD-1047 in attenuatingethanol-inducedneurotoxicityin vitro, and additional research is being conducted on this compound as a possible pharmacotherapy for alcohol use disorder (AUD)[3]
![]() | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |